Literature DB >> 16184221

Prevalence and risk factors of hepatitis C virus infection in hemodialysis patients from one center in Recife, Brazil.

Ana Cecília C de Albuquerque1, Maria Rosângela Cd Coêlho, Edmundo Pa Lopes, Marcilio Figueiredo Lemos, Regina Célia Moreira.   

Abstract

A hemodialysis population from a dialysis unit in the city of Recife, Northeastern Brazil, was screened to assess the prevalence of hepatitis C virus (HCV) infection and to investigate the associated risk factors. Hemodialysis patients (n = 250) were interviewed and serum samples tested for anti-HCV antibodies by enzyme-linked immunosorbent assay (ELISA). All samples were also tested for HCV RNA by reverse transcriptase nested polymerase chain reaction (RT-nested-PCR). Out of 250 patients, 21 (8.4%) were found to be seropositive by ELISA, and 19 (7.6%) patients were HCV RNA positive. HCV viraemia was present in 90.5% of the anti-HCV positive patients. The predominant genotype was HCV 1a (8/19), followed by 3a (7/19), and 1b (4/19). None of the anti-HCV negative patients were shown to be viraemic by the PCR. Univariate analysis of risk factors showed that time spent on hemodialysis, the number of blood transfusions and a blood transfusion before November 1993 were associated with HCV positivity. However, multivariate analysis revealed that blood transfusions before November 1993 were significantly associated with HCV infection in this population. Low prevalence levels were encountered in this center, however prospective studies are necessary to confirm these findings.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16184221     DOI: 10.1590/s0074-02762005000500003

Source DB:  PubMed          Journal:  Mem Inst Oswaldo Cruz        ISSN: 0074-0276            Impact factor:   2.743


  8 in total

1.  Prevalence and incidence of hepatitis C virus in hemodialysis patients in British Columbia: Follow-up after a possible breach in hemodialysis machines.

Authors:  Andrew W Tu; Jane A Buxton; Mandy Whitlock; Ognjenka Djurdjev; Mei Chong; Mel Krajden; Monica Beaulieu; Adeera Levin
Journal:  Can J Infect Dis Med Microbiol       Date:  2009       Impact factor: 2.471

2.  A shield against a monster: Hepatitis C in hemodialysis patients.

Authors:  Seyed-Moayed Alavian
Journal:  World J Gastroenterol       Date:  2009-02-14       Impact factor: 5.742

Review 3.  Management of hepatitis C virus infection in hemodialysis patients.

Authors:  Yue-Cheng Yu; Yue Wang; Chang-Lun He; Mao-Rong Wang; Yu-Ming Wang
Journal:  World J Hepatol       Date:  2014-06-27

4.  Prevalence and risk factors of hepatitis B and C viruses among haemodialysis patients in Gaza strip, Palestine.

Authors:  Abed El-kader Y El-Ottol; Abdelraouf A Elmanama; Basim M Ayesh
Journal:  Virol J       Date:  2010-09-01       Impact factor: 4.099

5.  Detection of hepatitis C virus in patients with terminal renal disease undergoing dialysis in southern Brazil: prevalence, risk factors, genotypes, and viral load dynamics in hemodialysis patients.

Authors:  Beatris Maria Vidales-Braz; Naylê Maria Oliveira da Silva; Rubens Lobato; Fabiana Nunes Germano; Luiza Dias da Mota; Elvino J G Barros; Ana Maria Barral de Martinez
Journal:  Virol J       Date:  2015-02-03       Impact factor: 4.099

6.  Hepatitis C and G Virus Infection Prevalence Among Hemodialysis Patients and Associated Risk Factors in the Hormozgan Province of Southern Iran.

Authors:  Ali Kargar Kheirabad; Fahime Bahri; Mohammad Kargar; Iman Ghasemzadeh
Journal:  Hepat Mon       Date:  2016-08-13       Impact factor: 0.660

7.  Persistently high hepatitis C rates in haemodialysis patients in Brazil [a systematic review and meta-analysis].

Authors:  Roberta Pereira Niquini; Jurema Corrêa da Mota; Leonardo Soares Bastos; Diego da Costa Moreira Barbosa; Juliane da Silva Falcão; Paloma Palmieri; Patrícia Martins; Livia Melo Villar; Francisco I Bastos
Journal:  Sci Rep       Date:  2022-01-10       Impact factor: 4.996

8.  Evidence of association between hepatitis C virus genotype 2b and nosocomial transmissions in hemodialysis centers from southern Brazil.

Authors:  Naylê Maria Oliveira da Silva; Fabiana Nunes Germano; Raul Andres Mendoza-Sassi; Hector Nicolas Seuánez; Marcelo Alves Soares; Ana Maria Barral de Martinez
Journal:  Virol J       Date:  2013-05-29       Impact factor: 4.099

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.